News

IDDO’s latest newsletter is out

IDDO’s Director recognised as an ASTMH Distinguished International Fellow for 2022

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

IDDO’s latest newsletter is out

IDDO at the Geneva Health Forum 4 May 2022

ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients

Applications open for RSTMH 2022 grant programme

ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide

IDDO to make its COVID-19 studies discoverable on the Vivli platform

IDDO to share latest research at ECTMIH 2021

Preprints: it’s time to agree on terminology and best practice

ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination